References
- Yamada T. Therapeutic monoclonal antibodies. Keio J Med. 2011;60:37–46.
- Liu JKH. The history of monoclonal antibody development 2013; progress, remaining challenges and future innovations. Ann Med Surg. 2014;3:113–116.
- Weiner LM, Surana R, Wang S. Monoclonal antibodies: versatile platforms for cancer immunotherapy. Nat Rev Immunol. 2010;10:317–327.
- Boyiadzis M, Foon KA. Approved monoclonal antibodies for cancer therapy. Expert Opin Biol Ther. 2008;8:1151–1158.
- Teo EC, Chew Y, Phipps C. A review of monoclonal antibody therapies in lymphoma. Crit Rev OncolHematol. 2016;97:72–84.
- Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. MAbs. 2015;7:9–14.
- Gikanga B, Turok R, Hui A, et al. Manufacturing of high-concentration monoclonal antibody formulations via spray drying-the road to manufacturing scale. PDA J Pharm Sci Technol PDA. 2015;69:59–73.
- Draber P, Draberova E, Novakova M. Stability of monoclonal IgM antibodies freeze-dried in the presence of trehalose. J Immunol Methods. 1995;181:37–43.
- Goshima H, Forney-Stevens KM, Liu M, et al. Addition of monovalent electrolytes to improve storage stability of freeze-dried protein formulations. J Pharm Sci. 2016;105:530–541.
- Aulbach AD, Amuzie CJ. Chapter 17 - biomarkers in nonclinical drug development A2. A comprehensive guide to toxicology in nonclinical drug development (2nd Edn). Boston: Academic Press; 2017.
- Abdul‐Fattah AM, Kalonia DS, Pikal MJ. The challenge of drying method selection for protein pharmaceuticals: product quality implications. J Pharm Sci. 2007;96:1886–1916.
- Pikal-Cleland KA, Carpenter JF. Lyophilization-induced protein denaturation in phosphate buffer systems: monomeric and tetrameric beta-galactosidase. J Pharm Sci. 2001;90:1255–1268.
- Prestrelski SJ, Tedeschi N, Arakawa T, et al. Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers. Biophys J. 1993;65:661–671.
- Chang L, Shepherd D, Sun J, et al. Mechanism of protein stabilization by sugars during freeze-drying and storage: Native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci. 2005;94:1427–1444.
- Anchordoquy TJ, Carpenter JF. Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state. Arch Biochem Biophys. 1996;332:231–238.
- Izutsu K, Kojima S. Freeze-concentration separates proteins and polymer excipients into different amorphous phases. Pharm Res. 2000;17:1316–1322.
- Bhatnagar BS, Martin SW, Hodge TS, et al. Investigation of PEG crystallization in frozen and freeze-dried PEGylated recombinant human growth hormone-sucrose systems: implications on storage stability. J Pharm Sci. 2011;100:3062–3075.
- Castellanos IJ, Flores G, Griebenow K. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres. J Pharm Pharmacol. 2005;57:1261–1269.
- Lale SV, Goyal M, Bansal AK. Development of lyophilization cycle and effect of excipients on the stability of catalase during lyophilization. Int J Pharma Invest. 2011;1:214–221.
- Moretton MA, Chiappetta DA, Sosnik A. Cryoprotection-lyophilization and physical stabilization of rifampicin-loaded flower-like polymeric micelles. J Roy Soc Interf. 2012;9:487–502.
- Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci. 2009;18:24–36.
- Draber P, Sulimenko V, Sulimenko T, et al. Stabilization of protein by freeze-drying in the presence of trehalose: a case study of tubulin. Methods Mol Biol. 2014;1129:443–458.
- Carpenter JF, Arakawa T, Crowe JH. Interactions of stabilizing additives with proteins during freeze-thawing and freeze-drying. Dev Biol Standard. 1992;74:225–238.
- Srirangsan P, Kawai K, Hamada-Sato N, et al. Improvement in the remaining activity of freeze-dried xanthine oxidase with the addition of a disaccharide–polymer mixture. Food Chem. 2010;119:209–213.
- Carpenter JF, Prestrelski SJ, Arakawa T. Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies. Arch Biochem Biophys. 1993;303:456–464.
- Pickles J, Rafiq S, Cochrane SA, et al. In vitro pepsin resistance of proteins: effect of non-reduced SDS-PAGE analysis on fragment observation. Toxicol Reports. 2014;1:858–870.
- Kamerzell TJ, Esfandiary R, Joshi SB, et al. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. Adv Drug Deliv Rev. 2011;63:1118–1159.
- Ohtake S, Kita Y, Arakawa T. Interactions of formulation excipients with proteins in solution and in the dried state. Adv Drug Deliv Rev. 2011;63:1053–1073.
- Faghihi H, Vatanara A, Najafabadi AR, et al. The use of amino acids to prepare physically and conformationally stable spray-dried IgG with enhanced aerosol performance. Int J Pharm. 2014;466:163–171.
- Blessy M, Patel RD, Prajapati PN, et al. Development of forced degradation and stability indicating studies of drugs—a review. J Pharm Anal. 2014;4:159–165.
- Faghihi H, Khalili F, Amini M, et al. The effect of freeze-dried antibody concentrations on its stability in the presence of trehalose and hydroxypropyl-beta-cyclodextrin: a Box-Behnken statistical design. Pharm Dev Technol. 2015;22:724–732.
- Randolph TW. Phase separation of excipients during lyophilization: effects on protein stability. J Pharm Sci. 1198;86:203.
- Cuevas-Velazquez CL, Rendon-Luna DF, Covarrubias AA. Dissecting the cryoprotection mechanisms for dehydrins. Front Plant Sci. 2014;5:583.
- Sundaramurthi P, Patapoff TW, Suryanarayanan R. Crystallization of trehalose in frozen solutions and its phase behavior during drying. Pharm Res. 2010;27:2374–2383.
- Arakawa T, Kita Y, Carpenter JF. Protein–solvent interactions in pharmaceutical formulations. Pharm Res. 1991;8:285–291.
- Allison SD, Chang B, Randolph TW, et al. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch Biochem Biophys. 1999;365:289–298.
- Rawat S, Raman Suri C, Sahoo DK. Molecular mechanism of polyethylene glycol mediated stabilization of protein. Biochem Biophys Res Commun. 2010;392:561–566.
- Carpenter JF, Crowe JH, Arakawa T. Comparison of solute-induced protein stabilization in aqueous solution and in the frozen and dried states. J Dairy Sci. 1990;73:3627–3636.
- Vazquez-Rey M, Lang DA. Aggregates in monoclonal antibody manufacturing processes. Biotechnol Bioeng. 2011;108:1494–1508.
- Akers MJ. Excipient-drug interactions in parenteral formulations. J Pharm Sci. 2002;91:2283–2300.
- Kramer RM, Shende VR, Motl N, et al. Toward a molecular understanding of protein solubility: increased negative surface charge correlates with increased solubility. Biophys J. 2012;102:1907–1915.
- Wang F, Liu Y, Li J, et al. On-column refolding of consensus interferon at high concentration with guanidine-hydrochloride and polyethylene glycol gradients. J Chromatogr A. 2006;1115:72–80.
- Katayama DS, Carpenter JF, Menard KP, et al. Mixing properties of lyophilized protein systems: a spectroscopic and calorimetric study. J Pharm Sci. 2009;98:2954–2969.
- Balcão VM, Vila MMDC. Structural and functional stabilization of protein entities: state-of-the-art. Adv Drug Deliv Rev. 2015;93:25–41.
- Tzannis ST, Prestrelski SJ. Activity-stability considerations of trypsinogen during spray drying: effects of sucrose. J Pharm Sci. 1999;88:3518.
- Izutsu K-i, Yoshioka S, Kojima S. Physical stability and protein stability of freeze-dried cakes during storage at elevated temperatures. Pharm Res. 1994;11:995–999.
- Andersson MM, Hatti-Kaul R. Protein stabilising effect of polyethyleneimine. J Biotechnol. 1999;72:21–31.
- Yuan W, Wu F, Geng Y, et al. Preparation of dextran glassy particles through freezing-induced phase separation. Int J Pharm. 2007;339:76–83.